Cell and gene therapies are placing the patient at the center of the supply chain in a vastly new way, with implications for production, financial operations, product ordering, logistics and patient access and support. With these high-value therapies gaining more acclaim and moving from academic treatment centers to community care, their therapeutic and commercial success will be more highly scrutinized. In this webinar, commercial, patient access and clinical supply chain leaders will gain:
- A step-by-step understanding of the cell and gene therapy patient and product journey
- Insight into how to establish a seamlessly connected process between sites of care, patients, their healthcare providers and payers
- Lessons from experts at the forefront of this new therapy paradigm
- Practical advice on pivotal questions related to product ordering, patient hub design and payer considerations
